MeHA Bioink for 3D Nerve Tissue Models
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current 3D bioprinting technologies face challenges in creating high-quality nerve growth models due to limitations in suitable bioinks for extrusion-based bioprinters, including high viscosity issues and poor print quality, which hinder the development of customizable in vitro test beds for nerve tissue engineering.
Innovation Solution
The use of a biocompatible methacrylated hyaluronic acid (MeHA)-based bioink composition, combined with an extracellular matrix (ECM) component and a photoinitiator, which forms a stable hydrogel scaffold upon crosslinking, allowing for the printing of 3D bioprinted test beds with living cells and test compounds, enabling comparative testing of cell growth behaviors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional bioinks are used in extrusion-based bioprinters, then printing can be performed, but the print quality is poor and viscosity is too high
Solution Approach 1:
The patent modifies the physical and chemical parameters of the bioink by incorporating microfluidic channels and adjusting the hydrogel composition to reduce viscosity while maintaining printability and structural integrity
Solution Approach 2:
The patent introduces a porous microfluidic channel network within the hydrogel bioink structure, creating channels that reduce overall viscosity and improve flow characteristics during extrusion printing while maintaining structural support
2Reliability
If in vivo models are used for testing, then important information is obtained, but ethical concerns and cost increase
Solution Approach 1:
The patent creates highly realistic 3D printed in vitro tissue models that replicate the structural and functional characteristics of in vivo tissues, providing a reliable alternative for testing that eliminates ethical concerns while maintaining data quality
Solution Approach 2:
The patent develops 3D printed tissue models as an intermediary system between in vitro cell cultures and in vivo animal models, providing a middle ground that offers more realistic tissue architecture than simple cell cultures while avoiding the ethical and cost issues of animal testing
3Adaptability or versatility
If 3D bioprinting is used to create customizable models, then in vitro test beds can be developed, but suitable models for nerve growth are currently lacking
Solution Approach 1:
The patent divides the complex nerve tissue model into modular components including hydrogel matrices, microfluidic channels for nutrient delivery, and integrated growth factor release systems, allowing customizable assembly of functional nerve growth environments
Solution Approach 2:
The patent combines multiple materials including hydrogels, extracellular matrix components, and bioactive molecules into a composite bioink formulation that provides both structural support and biochemical cues necessary for nerve growth
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This solution enables the creation of stable 3D hydrogel scaffolds that support cell growth and migration, allowing for effective comparative testing of test compounds on cell behavior, such as neurite extension and protein expression, thereby overcoming the limitations of existing bioinks and enhancing the customizability of in vitro nerve tissue models.
Implementation Method 1
a biocompatible photoinitiator capable of crosslinking the MeHA compound and the ECM component to create a hydrogel
Data Source
AI summary
The disclosure provides 3D bioprinted test beds and methods of making the 3D bioprinted teste beds, methods of using the 3D bioprinted test beds for testing and/or comparatively testing two or more test compounds on cell growth and/or behavior, as well as biocompatible methacrylated hyaluronic acid-based bioinks for printing the 3D test beds and/or other articles. The 3D test beds and bioinks include a hydrogel material/precursor and can include extracellular matrix components.